News
KARACHI: The body of a 23-year-old Pakistani man, who died during treatment in a hospital in Chennai, was brought to Karachi ...
4h
Sportschosun on MSNMay 5th is World Lung Hypertension Day...Middle-aged female caution, average survival of only 2-3 years when it worsensChildren's Day on May 5th is also 'World Pulmonary Hypertension Day'. Pulmonic Hypertension (PH) is a disease in which ...
If you have chronic obstructive pulmonary disease (COPD), your airways may be inflamed. It may be hard to take deep breaths and get enough oxygen.
Last year, the FDA approved the biologic drug Dupixent to treat uncontrolled eosinophilic COPD. The approval marked a step ...
Researchers have shown that activation of the protein YAP, which helps tumours grow, differs between two- and three-dimensional culture models, pointing to more predictive systems for testing cancer ...
The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2 ...
Non-small cell lung cancer (NSCLC) remains one of the leading causes of cancer-related deaths globally, and Ghana is no ...
Combining immunotherapy with chemotherapy shows promise in enhancing survival rates for extensive-stage small cell lung ...
Topline data were announced from a phase 3 trial evaluating tarlatamab for the treatment of SCLC in patients who progressed on or after a single line of platinum-based chemotherapy.
A panelist discusses how the MARIPOSA, SKIPPirr, and COCOON studies highlight the significant overall survival benefit of the ...
Zongertinib Shows Durable Responses With No Interstitial Lung Disease in HER2-Mutated Advanced NSCLC
Zongertinib, an oral therapy shown to have strong responses in patients previously treated for HER2 -mutated non–small cell ...
Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results